|
1- hexadecanoyl- 2- (4E,7E,10E,13E,16E,19E- docosahexaenoyl)- sn- glycero- 3- phosphocholine |
|
CHEBI:84797 |
|
1-hexadecanoyl-2-(4E,7E,10E,13E,16E,19E-docosahexaenoyl)-sn-glycero-3-phosphocholine |
|
A phosphatidylcholine 38:6 in which the acyl groups at C-1 and C-2 are specified as palmitoyl and (4E,7E,10E,13E,16E,19E)-docosahexaenoyl respectively. |
|
![](images/goldenstar.gif) ![](images/goldenstar.gif)
This entity has been manually annotated by the ChEBI Team.
|
|
|
|
Molfile
XML
SDF
|
|
|
|
InChI=1S/C46H80NO8P/c1- 6- 8- 10- 12- 14- 16- 18- 20- 21- 22- 23- 24- 25- 27- 29- 31- 33- 35- 37- 39- 46(49) 55- 44(43- 54- 56(50,51) 53- 41- 40- 47(3,4) 5) 42- 52- 45(48) 38- 36- 34- 32- 30- 28- 26- 19- 17- 15- 13- 11- 9- 7- 2/h8,10,14,16,20- 21,23- 24,27,29,33,35,44H,6- 7,9,11- 13,15,17- 19,22,25- 26,28,30- 32,34,36- 43H2,1- 5H3/b10- 8+,16- 14+,21- 20+,24- 23+,29- 27+,35- 33+/t44- /m1/s1 |
IESVDEZGAHUQJU-PYFUMDFMSA-N |
CCCCCCCCCCCCCCCC(=O) OC[C@H] (COP([O- ] ) (=O) OCC[N+] (C) (C) C) OC(=O) CC\C=C\C\C=C\C\C=C\C\C=C\C\C=C\C\C=C\CC |
|
mouse metabolite
Any mammalian metabolite produced during a metabolic reaction in a mouse (Mus musculus).
metabolite
Any intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
(via phosphatidylcholine 38:6 )
|
|
View more via ChEBI Ontology
Outgoing
|
1- hexadecanoyl- 2- (4E,7E,10E,13E,16E,19E- docosahexaenoyl)- sn- glycero- 3- phosphocholine
(CHEBI:84797)
has functional parent
hexadecanoic acid
(CHEBI:15756)
1- hexadecanoyl- 2- (4E,7E,10E,13E,16E,19E- docosahexaenoyl)- sn- glycero- 3- phosphocholine
(CHEBI:84797)
has role
mouse metabolite
(CHEBI:75771)
1- hexadecanoyl- 2- (4E,7E,10E,13E,16E,19E- docosahexaenoyl)- sn- glycero- 3- phosphocholine
(CHEBI:84797)
is a
phosphatidylcholine 38:6
(CHEBI:64519)
|
|
(2R)- 2- [(4E,7E,10E,13E,16E,19E)- docosa- 4,7,10,13,16,19- hexaenoyloxy]- 3- (hexadecanoyloxy)propyl 2- (trimethylammonio)ethyl phosphate
|
PC(16:0/22:6(4E,7E,10E,13E,16E,19E))
|
LIPID MAPS
|
PC(16:0/22:6)
|
LIPID MAPS
|
|